Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
City of Hope, Duarte, California Dana-Farber Cancer Institute, Boston, Massachusetts University of Minnesota, Minneapolis, Minnesota Memorial Sloan Kettering Cancer Center, New York, New York Fred Hutchinson Cancer Center, Seattle, Washington